Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • MARK4- One of the key players behind the onset of AD

Herpes infection can impair human brain development

Merck Pharma Regulatory Advocacy Job For Life Science | Apply Online

MARK4- One of the key players behind the onset of AD
  • BiotechToday
  • India

MARK4- One of the key players behind the onset of AD

bioxone October 28, 2020October 28, 2020

Avipsha Datta, Department of Biophysics, University of Calcutta

Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that impairs brain function and memory. Neurons degenerate, disrupting the neural networks and thereby destroys our memory and other important motor functions. AD is thought to be caused by the abnormal build-up of proteins aggregates in and around the brain cells. One of the proteins involved is called amyloid which deposits in the form of plaques around brain cells. The other protein is called tau which deposits in the form of tangles within the brain cells.

What exactly leads to the aggregate of these protein bodies have intrigued the scientists for decades? Various theories have come up, but yet waiting to come to up to a definite cause. One of the latest studies by a group of Japanese researchers has shown that the enzyme MARK4 (Microtubule Affinity Regulating Kinase 4) plays an important role in the aggregation of Tau protein particles.

Under normal conditions, the Tau protein is an important part of the structure of cells or cytoskeleton. MARK 4 helps Tau to detach from the arms of the cytoskeleton or microtubules constantly assembling and disassembling. 

But, when a mutation is incorporated in the MARK 4 gene, the problem arises. The Japanese team had artificially introduced a mutation in the MARK4 gene into a transgenic Drosophila fly, capable of expressing human Tau proteins and studied the changes of the protein in vivo. 

They observed that this pathological form of Tau had an excess of certain chemical groups that causes it to misfold. It was also observed that the Tau proteins much easily aggregated and were insoluble in detergents. These made it easier for the Tau to form the tangled clumps that caused the neurons to degenerate.

Previously, MARK 4 has also been found to play important roles in a wide range of other diseases which involved aggregation and build-up of other proteins. 

MARK4 thus plays a critical role in the onset of AD. The team’s insights might lead to a breakthrough in the development of treatments and preventive measures for these terminal neurodegenerative conditions.

Also read: Intracellular transfer of Vax1

References: https://www.timesnownews.com/health/article/japanese-researchers-discover-new-mechanism-that-causes-alzheimer-s-disease/673151

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Alzheimers Alzheimers gene Alzheimers prevention Alzheimers treatments amyloid-beta clinical research cure genetic identification genetic mutation MARK 4 motor functions Protein Psychiatry Tau

One thought on “MARK4- One of the key players behind the onset of AD”

  1. Pingback: Significance of Clinical correlations of SARS-CoV-2 antibody responses - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Merck Pharma Regulatory Advocacy Job For Life Science | Apply Online

bioxone October 28, 2020

-Shristi Sharma, Team bioXone Merck Life Sciences Vacancy For MSc/PhD – Apply Online. MSc/PhD Life Science/candidates apply online for Expert, Pharm Regulatory Advocacy position at Merck. Interested and eligible candidates check all the below: Job Title: Expert, Pharm Regulatory Advocacy Job Requisition ID: 208118 Location: Mumbai Your role: The candidate will be a key regulatory […]

Related Post

  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COMPUTER DESIGNED SYNTHETIC ANTIVIRAL PROTEINS INHIBIT SARS-COV 2/COVID 19 IN HUMAN CELLS

bioxone September 15, 2020September 15, 2020

–Rishav Chakraborty, Calcutta National Medical College, Kolkata The SARS-COV infection occurred first in 2003-2004. The infection is believed to be contracted from animals including monkeys, Himalayan palm civets, cats, dogs, and rodents. Clinical manifestation including myalgia, headache, sore throat, and fever followed by severe respiratory distress. The virus binds with the ACE-2 (Angiotensinogen Converting Enzyme) […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Ferroptosis and its novel role in cancer therapeutics

BioTech Today May 3, 2022May 2, 2022

Andrea Janet D’Souza, JAIN (Deemed – to – be) University Cancer is a disease that occurs due to uncontrolled cell division and an imbalance between cell proliferation and cell death. Programmed cell death or apoptosis can be induced in cancer cells through intrinsic and extrinsic pathways by the use of Caspases. Loss of apoptotic property […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Trimodal brain imaging may accurately detect human brain activities

BioTech Today July 15, 2021July 14, 2021

Parnad Basu, Amity University Kolkata The brain is the most complex part of the human body and controls what we do or feel, our reflexes, emotions, everything. However, we don’t know our brains fully. Scientists are continuously trying to decode how the human brain functions, pinpointing where, when, and how things happen in the brain. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy